These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2538205)

  • 1. Is the internal calcium regulation altered in type A botulinum toxin-poisoned motor endings?
    Mallart A; Molgó J; Angaut-Petit D; Thesleff S
    Brain Res; 1989 Feb; 479(1):167-71. PubMed ID: 2538205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In botulinum type A-poisoned frog motor endings ouabain induces phasic transmitter release through Na+-Ca2+ exchange.
    Molgo J; Angaut-Petit D; Thesleff S
    Brain Res; 1987 May; 410(2):385-9. PubMed ID: 3036311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum A toxin and tetanus toxin do not affect presynaptic membrane currents in mammalian motor nerve endings.
    Dreyer F; Mallart A; Brigant JL
    Brain Res; 1983 Jul; 270(2):373-5. PubMed ID: 6309330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features.
    Angaut-Petit D; Molgó J; Comella JX; Faille L; Tabti N
    Neuroscience; 1990; 37(3):799-808. PubMed ID: 1701041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mode of action of botulinum toxin type A at the frog neuromuscular junction.
    Molgó J; Thesleff S
    Brain Res; 1984 Apr; 297(2):309-16. PubMed ID: 6326941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation, augmentation and potentiation of transmitter release at frog neuromuscular junctions poisoned with botulinum toxin.
    Lupa MT; Tabti N
    Pflugers Arch; 1986 Jun; 406(6):636-40. PubMed ID: 2872654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of packets of acetylcholine and synaptic vesicle elicited by brown widow spider venom in frog motor nerve endings poisoned by botulinum toxin.
    Pumplin DW; del Castillo J
    Life Sci; 1975 Jul; 17(1):137-41. PubMed ID: 1079912
    [No Abstract]   [Full Text] [Related]  

  • 9. Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin.
    Kim YI; Lømo T; Lupa MT; Thesleff S
    J Physiol; 1984 Nov; 356():587-99. PubMed ID: 6520797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth in botulinum toxin poisoned muscles.
    Holland RL; Brown MC
    Neuroscience; 1981; 6(6):1167-79. PubMed ID: 7279219
    [No Abstract]   [Full Text] [Related]  

  • 11. The antagonism between botulinum toxin and calcium in motor nerve terminals.
    Gundersen CB; Katz B; Miledi R
    Proc R Soc Lond B Biol Sci; 1982 Oct; 216(1204):369-76. PubMed ID: 6129634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmitter release in botulinum-poisoned muscles.
    Thesleff S
    J Physiol (Paris); 1984; 79(4):192-5. PubMed ID: 6152289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A: kinetics of calcium dependent paralysis of the neuromuscular junction and antagonism by drugs and animal toxins.
    Metezeau P; Desban M
    Toxicon; 1982; 20(3):649-54. PubMed ID: 6125045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic actions of botulinal neurotoxins at vertebrate neuromuscular junctions.
    Molgo J; Comella JX; Angaut-Petit D; Pecot-Dechavassine M; Tabti N; Faille L; Mallart A; Thesleff S
    J Physiol (Paris); 1990; 84(2):152-66. PubMed ID: 2290130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionomycin-induced acetylcholine release and its inhibition by adenosine at frog motor nerve endings.
    Hunt JM; Silinsky EM
    Br J Pharmacol; 1993 Oct; 110(2):828-32. PubMed ID: 8242258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D.
    Molgó J; Siegel LS; Tabti N; Thesleff S
    J Physiol; 1989 Apr; 411():195-205. PubMed ID: 2575665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.
    Redman RS; Silinsky EM
    J Physiol; 1994 May; 477(Pt 1):117-27. PubMed ID: 8071878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of type D botulinum toxin on frog neuromuscular junctions.
    Harris AJ; Miledi R
    J Physiol; 1971 Sep; 217(2):497-515. PubMed ID: 4329008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sprouting of frog motor nerve terminals after long-term paralysis by botulinum type A toxin.
    Diaz J; Molgó J; Pécot-Dechavassine M
    Neurosci Lett; 1989 Jan; 96(2):127-32. PubMed ID: 2784552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.